However, in releasing the longer-lasting and more effective Wegovy, Novo's Saxenda has dwindled in market share, with analysts at GlobalData, parent company of Pharmaceutical Technology , forecasting that the drug's sales will plummet to just $135m in 2031 down 91% from $1.5bn peak sales in 2022
Characterization, health benefits, and food applications of enzymatic digestion- resistant dextrin: A review
Metabolism of dulaglutide is not renally dependent, making the drug a logical candidate for future study in type 2 diabetic patients with renal impairment, observed Dr
Delicious flavors: Green Apple, Orange Pulp & Pineapple Splash
BPC 157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice
Diabetes, Obesity and Metabolism, 15(1), 1527